Search for: "Deas v. Deas"
Results 101 - 120
of 793
Sort by Relevance
|
Sort by Date
10 Mar 2023, 7:08 am
Stevens v. [read post]
7 Mar 2023, 7:14 am
Notably, the proposed rules also give DEA-registered practitioners who have relied on the DEA’s emergency waiver—which, since January 2020, has allowed practitioners to prescribe Schedules II-V controlled substances without conducting a prior in-person medical evaluation of the patient—up to 180 days to come into compliance with the new in-person evaluation requirements that would be implemented in the final regulations. [read post]
2 Mar 2023, 9:05 pm
Supreme Court’s decision in Dobbs v. [read post]
1 Mar 2023, 8:00 am
Under the proposed rules, where a practitioner and patient established a telemedicine relationship during the PHE and where the practitioner, relying on the DEA waiver, prescribed Schedules II-V controlled substances to the patient without conducting an in-person medical evaluation of the patient, practitioners would be given 180-days to come into compliance with in-person evaluation requirements. [read post]
27 Feb 2023, 3:54 pm
The only schedule III-V narcotic drug that is currently approved by the FDA for OUD treatment is buprenorphine. [read post]
27 Feb 2023, 3:01 am
Aims Institute, PLLC, v. [read post]
12 Feb 2023, 8:09 am
See Page v. [read post]
25 Jan 2023, 9:05 pm
United States v. [read post]
17 Jan 2023, 10:17 am
The deliberate indifference claim recognized in Carlson v. [read post]
10 Jan 2023, 10:32 am
Davis discussed the end of U.S. v. [read post]
10 Jan 2023, 10:32 am
Davis discussed the end of U.S. v. [read post]
7 Jan 2023, 7:37 am
” * Jones v. [read post]
9 Nov 2022, 2:01 am
Other present defendants include AVM (a German Netgear competitor) and Amazon (presumably because of its WiFi-capable devices like Kindle and Echo).This Huawei v. [read post]
6 Sep 2022, 6:33 am
DOJ (D.D.C.) -- on third round of summary judgment, concluding that DEA properly relied on Exemption 7(E) to withhold portions of DEA’s Agents’ Manual.Ctr. for Medical Progress v. [read post]
1 Sep 2022, 6:57 am
Dale v. [read post]
26 Aug 2022, 6:54 am
Kendrick v. [read post]
16 Aug 2022, 9:25 am
Under U.S. v. [read post]
4 Aug 2022, 5:00 am
In FDA v. [read post]
30 Jul 2022, 4:13 pm
BrazilRicardo Zarattini Filho v. [read post]
29 Jul 2022, 3:33 pm
In 2020, Purdue pleaded guilty to felony violations for conspiracy to defraud the Unites States and to violate the anti-kickback statute (AKS), admitting to paying prescribers kickbacks to induce them to prescribe OxyContin and to misrepresenting to the DEA that Purdue maintained an effective anti-diversion program when, in actuality, Purdue marketed OxyContin to over 100 health care providers who the company knew were diverting opioids, and agreed to pay $5.5 in criminal fines and… [read post]
